Association between EVD epidemic and availability of signal functions at healthcare facilities designated to provide BEmOC or CEmOC
| Availability of EmOC signal function (% of month–facility occasions when signal function available) | Effect of EVD epidemic | |||||||
|---|---|---|---|---|---|---|---|---|
| Facility providing BEmOC | Facility providing CEmOC | All facilities combined | ||||||
| EmOC signal function | No Ebola (n=1035) | Ebola (n=395) | No Ebola (n=207) | Ebola (n=79) | No Ebola (n=1242) | Ebola (n=474) | OR (95% CI) | p Value |
| 1. im/iv antibiotics | 95.7 | 96.5 | 95.7 | 93.7 | 95.7 | 96.0 | 1.01 (0.48 to 2.12) | 0.99 |
| 2. im/iv oxytocics | 94.1 | 91.7 | 95.2 | 92.4 | 94.3 | 91.8 | 0.67 (0.39 to 1.16) | 0.59 |
| 3. im/iv anticonvulsants | 97.6 | 98.0 | 95.7 | 96.2 | 97.3 | 97.7 | 1.99 (0.71 to 5.57) | 0.18 |
| 4. Manual removal of placenta | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | NV | |
| 5. Removal of retained products of conception | 79.7 | 84.3 | 100.0 | 100.0 | 83.1 | 86.9 | 1.65 (0.71 to 3.83) | 0.23 |
| 6. Assisted vaginal delivery | 84.4 | 81.3 | 100.0 | 100.0 | 87.0 | 84.4 | 0.45 (0.20 to 1.03) | 0.056 |
| 7. Neonatal resuscitation | 79.8 | 88.4 | 77.8 | 81.0 | 79.5 | 87.1 | NR | |
| 8. Blood transfusion | NA | NA | 91.3 | 86.1 | NA | NA | NE | |
| 9. Caesarean section | NA | NA | 91.6 | 91.6 | NA | NA | NV | |
BEmOC, basic emergency obstetric care; CEmOC, comprehensive emergency obstetric care; EmOC, emergency obstetric care; EVD, Ebola virus disease; im, intramuscular; iv, intravenous; n, number of facility–month combinations; NA, not applicable, signal function not expected at BEmOC facilities; NE, not estimable: in one district the initiation of availability of this signal function coincided with Ebola, in all others there is no variation over months; NV, no variation over time, within each facility, regarding availability of signal function.